Dr. ⁨Qiuju Tian⁩MD, PhD

Attending Physician, Liver Disease Center, The Affiliated Hospital of Qingdao University

The Affiliated Hospital of Qingdao UniversityChinaORCID 0000-0003-3764-5657

Talks given

Publications

Followers

About

Dr. Qiuju Tian is an Attending Physician in the Liver Disease Center at The Affiliated Hospital of Qingdao University. She holds both MD and PhD degrees and serves as Principal Investigator for the Natural Science Foundation of Shandong Province and Qingdao Municipal Natural Science Foundation. Dr. Tian also participates in the Youth Innovation and Technology Support Program of Shandong Universities.

Areas of focus

HepatologyLiver diseaseClinical hepatologyMedical researchNatural science research funding

Experience & education

Attending Physician · The Affiliated Hospital of Qingdao University

Liver Disease Center

Present

Principal Investigator · Natural Science Foundation of Shandong Province

Principal Investigator · Qingdao Municipal Natural Science Foundation

Participant, Youth Innovation and Technology Support Program · Shandong Universities

Publications

Understanding how hypoxia contributes to liver cancer stem cells maintenance.

Liu, Fengchao, Qian, Yanzhi, Zhang, Qun, Tian, Qiuju, Rao, Wei · Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026PubMed

IGF1/IGF1R signaling promotes the expansion of liver CSCs and serves as a potential therapeutic target in HCC.

Tian, Qiuju, Zhang, Qun, Wang, Bin, Qian, Yanzhi, Liu, Fengchao · Discover oncology · 2025PubMed

Protein-losing enteropathy and multiple vasculature dysplasia in LZTR1-related Noonan syndrome: A case report and review of literature.

Tian, Qiu-Ju, Zhang, Lu-Jia, Zhang, Qun, Liu, Feng-Chao, Xie, Man, Cai, Jin-Zhen, et al. · World journal of gastroenterology · 2025PubMed

Development and Validation of a Novel Model to Discriminate Idiosyncratic Drug-Induced Liver Injury and Autoimmune Hepatitis.

Wang, Yu, Lin, Xuhui, Sun, Ying, Liu, Jimin, Li, Jia, Tian, Qiuju, et al. · Liver international : official journal of the International Association for the Study of the Liver · 2025PubMed

Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study.

Wang, Jitao, Zhang, Qiran, Ai, Jingwen, Liu, Dengxiang, Liu, Chuan, Xiang, Huiling, et al. · Hepatology international · 2024PubMed

Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China.

Tian, Qiu-Ju, Xie, Man, Wang, Ji-Tao, Wang, Yi, Zhang, Bei, Cai, Jin-Zhen, et al. · Hepatobiliary & pancreatic diseases international : HBPD INT · 2022PubMed

Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study.

Ai, Jingwen, Wang, Jitao, Liu, Dengxiang, Xiang, Huiling, Guo, Ying, Lv, Jiaojian, et al. · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022PubMed

Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study.

Wang, Jitao, Zhang, Qiran, Ai, Jingwen, Liu, Dengxiang, Liu, Chuan, Xiang, Huiling, et al. · Hepatology international · 2022PubMed

An analysis report on the application of immune checkpoint inhibitors after liver transplantation.

Xie, Man, Dang, Zhi-Ping, Sun, Xue-Guo, Zhang, Bei, Zhang, Qun, Tian, Qiu-Ju, et al. · Therapeutic advances in chronic disease · 2022PubMed

Preliminary single-center experience of Helicobacter pylori eradication among the liver transplant recipients.

Xie, Man, Li, Qing, Zhang, Bei, Zhang, Qun, Tian, Qiu-Ju, Liu, Hong, et al. · Helicobacter · 2021PubMed

Connect

ORCID